Lang Walker pushes for QrXPharma board upheaval
Fresh from a multimillion-dollar loss on his investment in pain drug developer QrXPharma, rich list property developer Lang Walker is trying to eject founder Gary Pace and chairman Peter Farrell.
Fresh from a multimillion-dollar loss on his investment in pain drug developer QrXPharma , rich list property developer Lang Walker is trying to eject founder Gary Pace and chairman Peter Farrell of ResMed fame from the biotechnology company’s board.
The Sydney-based company has plunged in value after the US regulator advised against approval of its pain management drug Moxduo. Investors were shocked because QrXPharma had been considered likely to succeed where so many speculative biotechnology companies had failed before it.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles